IRS1 and hepatocellular carcinoma: In summary, CREB3 is identified as a suppressor of HCC progression in vitro and in vivo, which attributed to decreasing the phosphorylation of AKT by interfering interaction of INSR with IRS1 and transcriptionally activating RBM38.